Please read and agree to the terms and conditions of this site.
@xconomy.com 3 months ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com 4 months ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 4 months ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 10 months ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 1 year ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com 1 year ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 1 year ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com 1 year ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com 1 year ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com 1 year ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com 2 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More